NCT05667948View on ClinicalTrials.gov

Molecular Analysis and Treatment Options of Thymic Malignancies

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Thymic Epithelial TumorThymic CarcinomaThymic Cancer
Interventions
DRUG

Chemotherapy

different treatments based on the molecular analysis

Trial Locations (1)

200030

RECRUITING

Xiaomin Niu, Shanghai

All Listed Sponsors
lead

Shanghai Chest Hospital

OTHER

NCT05667948 - Molecular Analysis and Treatment Options of Thymic Malignancies | Biotech Hunter | Biotech Hunter